文献速递青光眼神经眼科

加利福尼亚州联邦医疗保险受益者中青光眼与昼夜节律睡眠障碍的关联

The Associations Between Glaucoma and Circadian Rhythm Sleep Disorders in California Medicare Beneficiaries.
PubMed 文献 · Am J Ophthalmol · 2025-06-20

本研究为横断面研究,纳入2019年加利福尼亚州≥65岁、具有A和B部分保险且至少有一次B部分索赔的联邦医疗保险受益者,采用多变量逻辑回归分析青光眼与昼夜节律睡眠障碍及任何睡眠-觉醒障碍的关联。结果显示,青光眼患者发生昼夜节律睡眠障碍的调整比值比为1.20(95%CI 1.06-1.35;P=0.0031),发生任何睡眠-觉醒障碍的调整比值比为1.12(95%CI 1.11-1.13;P<0.001)。作者认为需要进一步研究以明确这些关联的机制及青光眼治疗对睡眠-觉醒障碍的影响。

要点

  • 在加利福尼亚州联邦医疗保险受益者中,青光眼与昼夜节律睡眠障碍的调整比值比为1.20(95%CI 1.06-1.35;P=0.0031)。
  • 青光眼与任何睡眠-觉醒障碍的调整比值比为1.12(95%CI 1.11-1.13;P<0.001)。
  • 作者指出需要进一步研究以明确关联机制及青光眼治疗对睡眠-觉醒障碍的影响。

核心结论

  • 在2019年加利福尼亚州联邦医疗保险人群中,青光眼患者发生昼夜节律睡眠障碍和任何睡眠-觉醒障碍的可能性增加。

研究设计与样本

  • 横断面研究,纳入所有2019年加利福尼亚州≥65岁、具有A和B部分保险覆盖且至少有一次B部分索赔的联邦医疗保险受益者,共2,717,346人。

主要发现

  • 研究人群中,220,662人(8.1%)患有青光眼,3,202人(0.12%)患有昼夜节律睡眠障碍,355,390人(13.1%)患有任何睡眠-觉醒障碍。
  • 调整年龄、性别、种族和民族、年龄相关性黄斑变性、糖尿病视网膜病变、白内障、人工晶状体眼及查尔森合并症指数评分定义的全身疾病负担后,青光眼患者发生昼夜节律睡眠障碍的调整比值比为1.20(95%CI 1.06-1.35;P=0.0031),发生任何睡眠-觉醒障碍的调整比值比为1.12(95%CI 1.11-1.13;P<0.001),均以无青光眼者为参照。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the associations between glaucoma, circadian rhythm sleep disorders (CRSD), and any sleep-wake disorders in California (CA) Medicare beneficiaries. DESIGN: Cross-sectional study. SUBJECTS: All 2019 CA Medicare beneficiaries who were ≥65 years old, had both Parts A & B coverage, and had ≥1 Part B claim. METHODS: The primary exposure was a diagnosis of glaucoma as defined by International Classification of Diseases, 10th revision codes. The primary outcome was CRSD, and the secondary outcome was any sleep-wake disorder, defined by International Classification of Diseases, 10th revision codes. The associations between glaucoma, CRSD, and any sleep-wake disorders were estimated using multivariable logistic regression models adjusting for age, sex, race and ethnicity, age-related macular degeneration, diabetic retinopathy, cataracts, pseudophakia, and systemic disease burden defined by Charlson Comorbidity Index score. The effect estimate was expressed as an adjusted odds ratio (aOR) with a 95% confidence interval (CI). MAIN OUTCOME MEASURES: Odds ratios between exposures and outcomes. RESULTS: The study population included 2,717,346 CA Medicare beneficiaries meeting inclusion criteria. Of those, 220,662 (8.1%) had glaucoma, 3,202 (0.12%) had CRSD, and 355,390 (13.1%) had any sleep-wake disorder. In the adjusted logistic regression models, beneficiaries with glaucoma had greater adjusted odds of CRSD (aOR: 1.20; 95% CI: 1.06-1.35; P = .0031) and of any sleep-wake disorder (aOR: 1.12; 95% CI: 1.11-1.13; P < .001) compared to beneficiaries without glaucoma. CONCLUSIONS: In the 2019 CA Medicare population, beneficiaries with glaucoma had increased likelihood of CRSD and of any sleep-wake disorder. Further investigations are needed to characterize mechanisms of these associations and to examine the impact of glaucoma treatment on sleep-wake disorders.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ramirez M, Kitayama K, Puran A, et al. The Associations Between Glaucoma and Circadian Rhythm Sleep Disorders in California Medicare Beneficiaries. Am J Ophthalmol. 2025. PMID: 40545017. doi:10.1016/j.ajo.2025.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。